Bayer supports pharmaceutical research project

12:04 AM MST | November 30, 2012 | Deepti Ramesh

Bayer says that its Bayer HealthCare subsidiary and Leiden University (Leiden, Netherlands) will coordinate a newly founded international consortium, called kinetics for drug discovery (K4DD), which has been launched to explore a novel concept in drug discovery and to tackle a problem in the development of new drugs. Although successful in early phases of development, many drug candidates fail in clinical studies due to lack of efficacy, Bayer says. The new five-year project will focus on ‘optimizing binding kinetics’ for drug candidates with the goal...